Clinical Trial Update: Treatment With Lenalidomide, Bendamustine and Prednisone (RBP) in Patients With Relapsed or Refractory Multiple Myeloma [Phase 1, Phase 2]

View source ↗

Summary

This document provides an update on a Phase 1/2 clinical trial evaluating the combination of lenalidomide, bendamustine, and prednisone (RBP) in patients with r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Bendamustine (Bendamustine)
• Lenalidomide (lenalidomide)
• PREDNISONE (Prednisone)

Snippet

Sponsor: University of Leipzig | Conditions: Multiple Myeloma | Phase 1, Phase 2 | Status: UNKNOWN